Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Sweden Index MSCI Ishares | EWD | 17. avr 2025 | 41.90 | +2.02 |
Sweetgreen | SG | 17. avr 2025 | 18.48 | -6.62 |
Swiss Franc Trust | FXF | 17. avr 2025 | 108.37 | -0.65 |
Switzerland Alphadex First Trust | FSZ | 17. avr 2025 | 68.18 | -0.18 |
Switzerland Index MSCI Ishares | EWL | 17. avr 2025 | 51.95 | +1.29 |
SWK Holdings | SWKH | 17. avr 2025 | 18.05 | -0.33 |
Swvl Holdings A | SWVL | 17. avr 2025 | 2.91 | -5.21 |
SYLA Technologies Co., Ltd. - American Depositary Shares | SYT | 17. avr 2025 | 2.21 | 0.00 |
Sylvamo | SLVM | 17. avr 2025 | 60.73 | +2.10 |
Symbotic | SYM | 17. avr 2025 | 20.41 | +0.79 |
Synaptics | SYNA | 17. avr 2025 | 49.07 | +2.08 |
Synaptogenix | SNPX | 17. avr 2025 | 2.12 | -5.37 |
Synchronoss Technologies | SNCR | 17. avr 2025 | 9.76 | -0.51 |
Synchrony Financial | SYF | 17. avr 2025 | 47.87 | +2.37 |
Synchrony Financial Pref A | SYF-A | 17. avr 2025 | 17.19 | -0.29 |
Synchrony Financial Pref A | SYF-B | 17. avr 2025 | 24.46 | +1.07 |
Syndax Pharmaceuticals | SNDX | 17. avr 2025 | 11.54 | +4.43 |
Synergetics Inc | FTGC | 17. avr 2025 | 24.47 | +0.58 |
Synergy CHC | SNYR | 17. avr 2025 | 2.49 | -0.40 |
Synlogic | SYBX | 17. avr 2025 | 1.06 | +4.95 |
Synopsys | SNPS | 17. avr 2025 | 413.32 | -0.56 |
Synovus Financial | SNV | 17. avr 2025 | 41.29 | +1.90 |
Synovus Financial D Pref | SNV-D | 17. avr 2025 | 24.31 | -0.37 |
Synovus Financial E Pref | SNV-E | 17. avr 2025 | 25.35 | +0.84 |
Syntec Optics | OPTX | 17. avr 2025 | 1.24 | -6.06 |
Sypris Solutions | SYPR | 17. avr 2025 | 1.77 | +1.14 |
Syra Health | SYRA | 17. avr 2025 | 0.10 | -17.94 |
Syros Pharmaceuticals | SYRS | 17. avr 2025 | 0.13 | 0.00 |
Sysco | SYY | 17. avr 2025 | 71.74 | +1.49 |
System1 A | SST | 17. avr 2025 | 0.31 | +6.14 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.